In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine

William J. Jagust, Jamie L. Eberling, Jeffrey A Roberts, Kathleen M. Brennan, Stephen M. Hanrahan, Henry VanBrocklin, Joel D. Enas, Anat Biegon, Chester A. Mathis

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Previous experiments have demonstrated that 5-iodo-6-nitro-2-piperazinyquinoline (5-I-6-NQP) is a potent and selective ligand for studying brain 5-hydroxytryptamine (5-HT) reuptake sites. We performed in vivo imaging in non-human primates using single photon emission computed tomography (SPECT) and the 123I-labeled compound [123I]5-I-6-NQP. These studies showed rapid brain uptake, with slow egress of the tracer from the brainstem, a region rich in 5-HT reuptake sites. Loss of the tracer from regions with a lower density of these sites, such as cerebellum, was relatively more rapid. Pretreatment of animals with parozetine increased the washout of tracer from the brainstem to rates similar to that seen in cerebellum. Brainstem to cerebellar ratios of tracer accumulation were >2 by 8 h after injection, and in paroxetine pretreated animals remained close to 1. These results indicate that the radiotracer has characteristics suitable for use as a SPECT imaging agent of serotonin reuptake sites.

Original languageEnglish (US)
Pages (from-to)189-193
Number of pages5
JournalEuropean Journal of Pharmacology
Volume242
Issue number2
DOIs
StatePublished - Sep 28 1993

Fingerprint

Single-Photon Emission-Computed Tomography
Primates
Brain Stem
Serotonin
Cerebellum
Brain
Serotonin Agents
Paroxetine
Ligands
Injections
6-nitroquipazine
5-iodo-6-nitro-2-piperazinylquinoline

Keywords

  • 5-HT (5-hydroxytryptamine, serotonin)
  • Brain (primate)
  • SPECT(single photon emission computed tomography)

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine. / Jagust, William J.; Eberling, Jamie L.; Roberts, Jeffrey A; Brennan, Kathleen M.; Hanrahan, Stephen M.; VanBrocklin, Henry; Enas, Joel D.; Biegon, Anat; Mathis, Chester A.

In: European Journal of Pharmacology, Vol. 242, No. 2, 28.09.1993, p. 189-193.

Research output: Contribution to journalArticle

Jagust, William J. ; Eberling, Jamie L. ; Roberts, Jeffrey A ; Brennan, Kathleen M. ; Hanrahan, Stephen M. ; VanBrocklin, Henry ; Enas, Joel D. ; Biegon, Anat ; Mathis, Chester A. / In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine. In: European Journal of Pharmacology. 1993 ; Vol. 242, No. 2. pp. 189-193.
@article{0cc6cd1fc8b1452e890a192801b30742,
title = "In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine",
abstract = "Previous experiments have demonstrated that 5-iodo-6-nitro-2-piperazinyquinoline (5-I-6-NQP) is a potent and selective ligand for studying brain 5-hydroxytryptamine (5-HT) reuptake sites. We performed in vivo imaging in non-human primates using single photon emission computed tomography (SPECT) and the 123I-labeled compound [123I]5-I-6-NQP. These studies showed rapid brain uptake, with slow egress of the tracer from the brainstem, a region rich in 5-HT reuptake sites. Loss of the tracer from regions with a lower density of these sites, such as cerebellum, was relatively more rapid. Pretreatment of animals with parozetine increased the washout of tracer from the brainstem to rates similar to that seen in cerebellum. Brainstem to cerebellar ratios of tracer accumulation were >2 by 8 h after injection, and in paroxetine pretreated animals remained close to 1. These results indicate that the radiotracer has characteristics suitable for use as a SPECT imaging agent of serotonin reuptake sites.",
keywords = "5-HT (5-hydroxytryptamine, serotonin), Brain (primate), SPECT(single photon emission computed tomography)",
author = "Jagust, {William J.} and Eberling, {Jamie L.} and Roberts, {Jeffrey A} and Brennan, {Kathleen M.} and Hanrahan, {Stephen M.} and Henry VanBrocklin and Enas, {Joel D.} and Anat Biegon and Mathis, {Chester A.}",
year = "1993",
month = "9",
day = "28",
doi = "10.1016/0014-2999(93)90079-W",
language = "English (US)",
volume = "242",
pages = "189--193",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine

AU - Jagust, William J.

AU - Eberling, Jamie L.

AU - Roberts, Jeffrey A

AU - Brennan, Kathleen M.

AU - Hanrahan, Stephen M.

AU - VanBrocklin, Henry

AU - Enas, Joel D.

AU - Biegon, Anat

AU - Mathis, Chester A.

PY - 1993/9/28

Y1 - 1993/9/28

N2 - Previous experiments have demonstrated that 5-iodo-6-nitro-2-piperazinyquinoline (5-I-6-NQP) is a potent and selective ligand for studying brain 5-hydroxytryptamine (5-HT) reuptake sites. We performed in vivo imaging in non-human primates using single photon emission computed tomography (SPECT) and the 123I-labeled compound [123I]5-I-6-NQP. These studies showed rapid brain uptake, with slow egress of the tracer from the brainstem, a region rich in 5-HT reuptake sites. Loss of the tracer from regions with a lower density of these sites, such as cerebellum, was relatively more rapid. Pretreatment of animals with parozetine increased the washout of tracer from the brainstem to rates similar to that seen in cerebellum. Brainstem to cerebellar ratios of tracer accumulation were >2 by 8 h after injection, and in paroxetine pretreated animals remained close to 1. These results indicate that the radiotracer has characteristics suitable for use as a SPECT imaging agent of serotonin reuptake sites.

AB - Previous experiments have demonstrated that 5-iodo-6-nitro-2-piperazinyquinoline (5-I-6-NQP) is a potent and selective ligand for studying brain 5-hydroxytryptamine (5-HT) reuptake sites. We performed in vivo imaging in non-human primates using single photon emission computed tomography (SPECT) and the 123I-labeled compound [123I]5-I-6-NQP. These studies showed rapid brain uptake, with slow egress of the tracer from the brainstem, a region rich in 5-HT reuptake sites. Loss of the tracer from regions with a lower density of these sites, such as cerebellum, was relatively more rapid. Pretreatment of animals with parozetine increased the washout of tracer from the brainstem to rates similar to that seen in cerebellum. Brainstem to cerebellar ratios of tracer accumulation were >2 by 8 h after injection, and in paroxetine pretreated animals remained close to 1. These results indicate that the radiotracer has characteristics suitable for use as a SPECT imaging agent of serotonin reuptake sites.

KW - 5-HT (5-hydroxytryptamine, serotonin)

KW - Brain (primate)

KW - SPECT(single photon emission computed tomography)

UR - http://www.scopus.com/inward/record.url?scp=0027485096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027485096&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(93)90079-W

DO - 10.1016/0014-2999(93)90079-W

M3 - Article

C2 - 8253114

AN - SCOPUS:0027485096

VL - 242

SP - 189

EP - 193

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -